Brief: Kuros Provides Update On Planned Capital Increase

Kuros Biosciences AG

15/10/2020 06:07

Oct 15 (Reuters) - KUROS BIOSCIENCES AG  KURN.S :
    * PROVIDES AN UPDATE ON THE PLANNED CAPITAL INCREASE
    * OBTAINED ON OCT 14, 2020 AFTER MARKET CLOSE A BINDING
COMMITMENT
FROM OPTIVERDER B.V. TO FULLY EXERCISE ALL SUBSCRIPTION RIGHTS
ALLOCATED TO INVESTOR IN RIGHTS OFFERING AND TO PURCHASE
1,915,203 OFFERED SHARES
    * OBTAINED COMMITMENT FROM OPTIVERDER TO FULLY EXERCISE ALL
SUBSCRIPTION RIGHTS AND BUY 1,915,203 OFFERED SHARES AT
SUBSCRIPTION PRICE OF CHF 1.80 PER OFFERED SHARE IN SHARE
OFFERING FOR AN AGGREGATE AMOUNT OF CHF 3,447,365
    * EXACT NUMBER OF OFFERED SHARES SOLD IN RIGHTS OFFERING
WILL BE
PUBLISHED IN ELECTRONIC MEDIA AND BY PRESS RELEASE ON OCTOBER
19, 2020
    * LISTING AND FIRST DAY OF TRADING OF NEW REGISTERED SHARES
ON SIX
SWISS EXCHANGE EXPECTED TO TAKE PLACE ON OCTOBER 23, 2020
    * INTENDS TO USE ADDITIONAL NET PROCEEDS (IF ANY) TO FURTHER
STRENGTHEN COMMERCIAL OPERATION OF MAGNETOS
    * OFFERING SHALL BE SUPPLEMENTED BY ADDITIONAL TRANCHE OF UP
TO
1,915,203 ADDITIONAL SHARES ( "ADDITIONAL SHARES") EQUIVALENT TO
22.7% OF PREVIOUSLY ANNOUNCED OFFERED SHARES

Source text: https://bit.ly/3drcNH0
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))